Decellularized cartilage matrix as a novel biomatrix for cartilage tissue-engineering applications

Cartilage damage in the head, neck, and joints remains a clinical challenge. Trauma, surgery, and birth defects often lead to cartilage loss. Current repair methods lack durability and ease of use. No widely accepted replacement matrix exists for these areas. Existing materials face limitations in handling and mechanical stability. Researchers seek better scaffolds that support cell growth and matrix formation. Natural biomatrices are being explored for their compatibility and adaptability. This study introduces a new approach to decellularize cartilage for tissue engineering.

The study aimed to develop a decellularized cartilage matrix for tissue engineering. The goal was to create a scaffold that supports cell growth and avoids cytotoxic effects. The focus was on human and porcine cartilage, including meniscus and nasal septum. The process needed to remove cells while preserving structural integrity. The matrix was tested for its ability to support chondrocyte and fibroblast growth. The researchers wanted to assess porosity, GAG content, and cell viability. They also aimed to evaluate the matrix’s potential for biomedical applications. The findings could lead to improved cartilage repair strategies.

The team used a chemical process to decellularize human and porcine cartilage tissues. Meniscus and nasal septum tissues were selected for processing. The decellularization method aimed to remove cells while preserving matrix structure. The matrix was analyzed for denatured collagen and glycosaminoglycan content. Cytotoxicity tests were performed using MTS assays on seeded cells. Human chondrocytes and murine fibroblasts were used for in vitro testing. Histology, electron microscopy, and μCT were used to assess structural changes. The results showed cell removal and matrix preservation without cytotoxic effects.

The decellularized matrix showed high porosity and complete cell removal. Glycosaminoglycan levels dropped significantly after processing. No cytotoxic effects were observed in the seeded cell cultures. Both chondrocytes and fibroblasts adhered and proliferated on the matrix. MTS assays confirmed cell viability and metabolic activity. Histological and μCT analyses supported structural integrity and porosity. The matrix retained biomechanical properties suitable for implantation. These findings suggest the matrix is a viable scaffold for cartilage regeneration.

The decellularized cartilage matrix supports cell growth and lacks cytotoxicity. The process preserves structural and biomechanical features of the original tissue. High porosity and GAG removal suggest a functional extracellular matrix scaffold. The matrix is compatible with both human and murine cells in vitro. The results indicate potential for use in cartilage tissue engineering. The matrix’s natural origin allows for customization in shape and size. It may serve as a versatile implant for various clinical applications. The authors propose further testing in preclinical models to confirm efficacy.